US 10647711
Azepin-2-one derivatives as RSV inhibitors
granted A61PA61P11/00A61P31/14
Quick answer
US patent 10647711 (Azepin-2-one derivatives as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P11/00, A61P31/14